Zhongxin Finance, April 28 (Reporter Zhang Ni) A few days ago, the Mental Health Branch of China Narcotics Association was officially announced in Beijing. Work.
A few days ago, the China Narcotics Association held the "Inaugural Conference of the Mental Health Branch of the China Narcotics Association and the 2nd China Narcotics Industry High Quality Development Forum" in Beijing.
This meeting is hosted by the China Narcotics Association and is in good mood.
Heads of relevant institutions such as China Narcotics Association, China Drug Administration and Research Association, and Mental Health Branch of China Narcotics Association attended the event.
The World Health Organization defines health as "health is a state of physical, psychological and social fullness, not just the absence of disease and infirmity".
A domestic study published in The Lancet Psychiatry shows that the lifetime prevalence of depression among Chinese adults is 6.8%, of which depression is 3.4%.
Of these patients with depressive disorders, only 9.5% had been treated by health services and only 0.5% had received adequate treatment.
People's mental and mental health issues have attracted more and more attention. In the past two years, as the new crown epidemic continues, the public's demand for mental and mental health services has also continued to rise.
The Mental Health Branch of China Narcotics Association was established this time to become a link and bridge connecting the government, enterprises and experts, and a platform for experts and enterprises to serve.
According to reports, the branch will carry out work in the following aspects in the future: first, the development, clinical research and application of narcotic drugs and psychotropic drugs, and prevention of abuse; second, to improve the clinical accessibility of psychiatric drugs and standardize the rational use of psychiatrists The third is to promote and improve the Internet platform diagnosis and treatment norms for psychiatry, and the development and standardized implementation of digital drugs and products; the fourth is to promote the high-quality development of the psychotropic drug industry, strengthen the construction of psychiatric specialist service capabilities, and participate in the formulation, implementation, and evaluation of relevant national policies. Promote the continuous improvement of the spiritual and psychological service system, and gradually shift to a community-based service model.
Hao Wei of the Institute of Mental Health of the Second Xiangya Hospital of Central South University serves as the chairman of the Mental Health Branch of the China Narcotics Association, and Chen Guanwei, the chairman, founder and CEO of Good Mood, serves as the vice-chairman of the East China Institute of Life Sciences of Peking University and other institutions. Serve as secretary.
(Finish)